Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
1(100.0%)
1Total
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04314557Completed

Renal Arterial Denervation in Sympathetic Dysautonomia

Role: lead

NCT02563626Completed

Coronary Artery Aneurysm Registry

Role: lead

NCT04778020Completed

International COVID-19 Clinical Evaluation Registry -2 (HOPE-2)

Role: lead

NCT02243137Phase 1Completed

Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate

Role: collaborator

All 4 trials loaded